A pilot clinical study of Δ(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

Δ(9)-Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth and angiogenesis in animal models, so their potential application as antitumoral drugs has been suggested. However, the antitumoral effect of cannabinoids has never been tested in humans. Here we report the first clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán, M, Duarte, M J, Blázquez, C, Ravina, J, Rosa, M C, Galve-Roperh, I, Sánchez, C, Velasco, G, González-Feria, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/
https://www.ncbi.nlm.nih.gov/pubmed/16804518
http://dx.doi.org/10.1038/sj.bjc.6603236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/
https://www.ncbi.nlm.nih.gov/pubmed/16804518
http://dx.doi.org/10.1038/sj.bjc.6603236

Ejemplares similares